Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
International Isotopes Acquires AMICI’s Line of Nuclear Lung Ventilation Products
International Isotopes, Inc. announced on June 21 that it acquired AMICI Inc.’s line of nuclear lung ventilation products. AMICI is a leading manufacturer and distributor of diagnostic and therapeutic products for lung ventilation. This includes masks, mouthpieces, backer/virus filters and the Swirler Radioaerosol System that maximizes airflow. The company was founded in 1978. The acquisition of AMICI’s nuclear lung ventilation products includes the manufacturing molds, device registrations, trademarks and all production rights. International Isotopes supplies sodium iodide I-131 as an FDA approved generic drug product and manufactures a full range of nuclear medicine... Read More »
Telix Expands Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical
Telix Pharmaceuticals Limited announced on June 21 it has entered into an agreement to acquire Lightpoint Medical and its SENSEI® radio-guided surgery business. Lightpoint Medical is a technology leader in precision-guided robotic cancer surgery. The company develops and markets miniaturized imaging and sensing tools for advanced intra-operative cancer detection. Lightpoint Medical has developed SENSEI, a miniaturized surgical gamma probe for minimally-invasive and robot-assisted surgery. Telix Pharmaceuticals Limited is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals. Telix is developing a portfolio of... Read More »
Avanos Medical Announces Agreement to Acquire Diros Technology
Avanos Medical, Inc. announced that it has entered into a definitive agreement to acquire Diros Technology Inc. in Markham, Canada. Diros Technology Inc. is a leading manufacturer of innovative radiofrequency products used to treat chronic pain conditions. Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients’ quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today’s most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its... Read More »
Arterex Acquires NextPhase Medical Devices LLC
Medical Device Inc. (d/b/a Arterex) announced on June 19 that it acquired NextPhase Medical Devices LLC for an undisclosed price. NextPhase is a class II and III medical device contract manufacturer of electromechanical devices, active implantable devices and single use disposables in North America. It provides design and engineering, manufacturing and assembly, quality and regulatory and supply chain and logistics management services, enabling its customers to bring low-to-medium volume complex medical devices to market. Arterex is a leading medical device contract manufacturer and leader in new product development and medical education in orthopedics. The company has pioneered the... Read More »
Devices to Digital: Insights into the Medical Devices and eHealth Markets in Q1:23
The Medical Devices Market: As of May 26, 2023, a total of 46 Medical Device deals have been announced this year, and 28 of those deals were announced during Q1:23. The Q1:23 deal total is comparable to the 27 deals announced during Q1:22, yet an 18% drop from the 56 deals announced between January 1, 2022, and May 26, 2022. M&A activity is also 25% down compared to the 35 Medical Device deals announced during Q1:21, and 6% lower than the 49 deals announced between January 1, 2021, and May 26, 2021. While M&A is down compared to recent Q1’s, considering we just had a few years of unprecedented upheaval, the market is still at a better place than it was before the COVID-19 pandemic.... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
